Table 1 Clinical characteristics, use of medication and fasting lipid variables in the no dietary advice and the dietary advice groups, and in the placebo (corn oil) and the n-3 PUFA supplemented groups. Median values (25, 75 percentiles) or proportions are given.
From: Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
No Diet Intervention | Diet Intervention | Placebo (corn oil) | n-3 PUFA | |
|---|---|---|---|---|
n | 279 | 279 | 281 | 282 |
Age (yrs)(range) | 70 (67, 76) | 70 (67, 73) | 70 (67, 72) | 70 (68, 73) |
Verified CVD % | 28 | 28 | 27 | 28 |
Diabetes % | 16 | 14 | 17 | 13 |
Hypertension % | 32 | 29 | 29 | 32 |
Smokers % | 33 | 35 | 33 | 35 |
Medications: % | ||||
Statins | 25 | 29 | 25 | 29 |
Acetylsalicylic acid | 27 | 25 | 28 | 25 |
βeta-blockers | 19 | 14 | 16 | 17 |
ACE-inhibitors | 17 | 13 | 15 | 15 |
Nitrates | 11 | 7 | 7 | 10 |
Total Cholesterol (mmol/L) | 6.4 (5.8, 7.0) | 6.3 (5.5, 6.9) | 6.3 (5.6, 6.8) | 6.3 (5.7, 7.1) |
HDL-C (mmol/L) | 1.4 (1.1, 1.6) | 1.4 (1.2, 1.6) | 1.4 (1.2, 1.6) | 1.4 (1.2, 1.6) |
LDL-C (mmol/L) | 4.1 (3.5, 4.8) | 4.0 (3.5, 4.6) | 4.1 (3.5, 4.6) | 4.1 (3.5, 4.8) |
Triglycerides (mmol/L) | 1.5 (1.3, 2.1) | 1.6 (1.1, 2.0) | 1.5 (1.1, 2.0) | 1.6 (1.1, 2.1) |